Soluble SLAMF7 is a predictive biomarker for elotuzumab therapy.
作者信息
Suzuki Atsushi, Kakugawa Satoshi, Miyoshi Masafumi, Hori Mitsuo, Suzuki Kenshi, Furukawa Yusuke, Ohta Kensuke
机构信息
Bristol-Myers Squibb K.K., Shinjuku, Tokyo, Japan.
Department of Hematology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
出版信息
Leukemia. 2020 Nov;34(11):3088-3090. doi: 10.1038/s41375-020-0860-7. Epub 2020 May 12.
PMID:32398792
Abstract
摘要
Zotero 插件